Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.SummaryDifference0.7%
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check32 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check75 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a Phase 3 study on pegcetacoplan for C3 glomerulopathy and related conditions, while adding new terminology related to C3 glomerulopathy and a new version revision number.SummaryDifference24%
Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.